Diagnostic Accuracy of PSMA-targeted 18F-Florastamin PET/CT in Intermediate-risk Patients With Suspected Prostate Cancer
18F-Florastamin PSMA PET/CT demonstrated comparable diagnostic accuracy to mpMRI, with the added benefit of higher specificity. These findings suggest that PSMA PET/CT could complement mpMRI in the diagnostic evaluation of intermediate-risk prostate cancer, enhancing patient stratification and aiding clinical decision-making.
Authors
- Byung Hoon Kim (ORCID: https://orcid.org/0000-0001-5272-6362)
- Hye Ra Jung (ORCID: https://orcid.org/0000-0002-1477-6606)
- Misun Choe (ORCID: https://orcid.org/0000-0002-1412-5360)
- Kyoung Sook Won (ORCID: https://orcid.org/0000-0001-7185-911X)
- Byoung Je Kim (ORCID: https://orcid.org/0000-0003-2669-1885)
- Teak Jun Shin (ORCID: https://orcid.org/0000-0001-6203-4036)
- Wonho Jung (ORCID: https://orcid.org/0000-0003-4954-3543)
- Jimin Yuei
- Hae Won Kim
Institutions
- Keimyung University (KR)
Publication Details
- Journal
- Clinical Nuclear Medicine
- Published
- 2025-05-05
- DOI
- https://doi.org/10.1097/rlu.0000000000005798
- Citations
- 1
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.52